|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2005-9-16
|
|
pubmed:abstractText |
Gastrointestinal (GI) disorders are one of the main adverse events in patients treated by mycophenolic acid (MPA). The aim of our prospective questionnaire-based study was to assess GI side-effects in de novo renal-transplant patients receiving either mycophenolate mofetil (MMF) or enteric-coated mycophenolate sodium (EC-MPS).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0931-0509
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2231-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16046517-Adult,
pubmed-meshheading:16046517-Diarrhea,
pubmed-meshheading:16046517-Female,
pubmed-meshheading:16046517-Gastrointestinal Diseases,
pubmed-meshheading:16046517-Graft Survival,
pubmed-meshheading:16046517-Humans,
pubmed-meshheading:16046517-Immunosuppressive Agents,
pubmed-meshheading:16046517-Kidney Transplantation,
pubmed-meshheading:16046517-Male,
pubmed-meshheading:16046517-Middle Aged,
pubmed-meshheading:16046517-Mycophenolic Acid,
pubmed-meshheading:16046517-Prospective Studies,
pubmed-meshheading:16046517-Questionnaires,
pubmed-meshheading:16046517-Tablets, Enteric-Coated,
pubmed-meshheading:16046517-Time Factors
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Questionnaire-based evaluation of gastrointestinal disorders in de novo renal-transplant patients receiving either mycophenolate mofetil or enteric-coated mycophenolate sodium.
|
|
pubmed:affiliation |
Department of Nephrology, Dialysis and Transplantation, CHU Rangueil, 1 avenue Jean Poulhès, TSA 50032, 31059 Toulouse Cedex 9, France. nassim.kamar@free.fr
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
